Dr. Stuart Newman: “It Seems to Me That We Are Headed for A Techno-Eugenic Future”
By Mohsen Abdelmoumen,
American Herald Tribune
| 09. 05. 2019
In your book Biotech Juggernaut, Hope, Hype, and Hidden Agendas of Entrepreneurial BioScience co-authored with Tina Stevens, you draw attention to the excesses of biotechnology and its ramifications with the world of money. Is biotechnology really at the service of the Man or has it become uncontrollable and dangerous for the human species?
Like all powerful socially implicated tools and methods, biotechnology can bring improvements to people’s lives while simultaneously increasing the advantage of the rich over everyone else or causing unintended damage. To take a well-known example, industrialization of farming has made agricultural products cheaper and eliminated much (although not all) backbreaking labor. But agribusiness has also done away with millions of jobs and placed remaining workers in physical and social danger. It has all but ended the innovative engagement with the natural world by farmers which, beginning in preindustrial times, yielded crops that have been among the greatest products of civilization. Factory farming of animals, moreover, is inexcusably cruel.
More recently, the introduction of gene-based biotechnologies in agriculture has made many of these things even worse. Industry favors...
Related Articles
By Carl Zimmer, The New York Times | 10.20.2026
For the first time, scientists say they have used viruses designed by artificial intelligence to treat a human patient.
Researchers announced on Tuesday that they had administered the virus, known as a phage, to a patient suffering from a deadly...
By Noah Fromson, HealthLab | 10.19.2026
Gene therapy is no longer the future of medicine — it’s reality. Treatments that replace, silence or edit genes are already changing clinical care.
There are more than 6,000 rare genetic disorders but only a fraction currently have treatable targets...
By Roxanne Khamsi, The Atlantic | 10.16.2026
In recent months, news came out about several distressing cases that have underscored the risks of gene therapy, which delivers DNA to a patient’s cells to treat disease. All of these cases have one thing in common that’s not apparent...
By Rebecca Roberts, The Scientist | 10.11.2026
Heritable genome editing in human embryos is once again under intense scrutiny after the publication of an opinion piece in Trends in Genetics at the end of last month.1 In the paper, Cathy Tie, the founder and chief...